Skip to main content
EuroGCT
Menu
Close
Help and support
Help and support
FAQ's
Glossary
FAQ's
How is the safety of a new gene therapy determined?
How are gene and cell therapies different to 'traditional' therapies?
Where do embryonic stem cells for research come from?
How is the production of gene and cell therapies different to traditional treatments?
Why do we need gene and cell therapies? How are they different from traditional medicines and treatments?
What is genetic testing?
Is it ethical to use animals in health and scientific research?
What are the roles of regulators in the development of gene and cell therapies?
See all FAQs
Glossary
Accelerated assessment
Adeno-associated virus (AAV)
Adenovirus
Adult stem cells
Advanced Therapy Investigational Medicinal Product (ATIMP)
Advanced Therapy Medicinal Product (ATMP)
Advertising
Antibody
See full Glossary
Search
Select language
Select language
English
Français
Deutsch
Italiano
Polski
Español
Português
Select language
Select language
English
Français
Deutsch
Italiano
Polski
Español
Português
Condition
Blood Disorders
Sickle Cell Disease
Cardiovascular Disease
Heart Disease
Stroke
Bowel Disease
Cancer
Cystic Fibrosis
Eye Disease
Immune Conditions
Diabetes
Multiple Sclerosis
Kidney Disease
Liver Disease
Lung Disease
Bone and Muscle Conditions
Muscular Dystrophy
Spinal Cord Injuries
Neurological Disorders
Alzheimer's Disease
Cerebral Palsy
Huntington's Disease
Motor Neurone Disease
Parkinson's Disease
Spinal Muscular Atrophy
Skin
Epidermolysis Bullosa
Reproduction and Fertility
Theme
Cell and Gene Fundamentals
Blood Stem Cells
Genes and Inheritance
Cord Blood
Embryonic Stem Cells
iPS cells
MSCs
Skin Stem Cells
Current and Potential Uses
Cell Therapy
Gene Therapy
Clinical Trials
CAR-T Therapy
Methods and Tools
Disease Modelling
Organoids
Tissue Engineering
Gene Editing
Reprogramming
Ethics and Society
Patient Involvement
Policy & Regulation
Unproven Treatments
Spotlight on Research
Main navigation
Discover
Discover
Educational Resources Directory
INTENS
LEARN
Research Pathways
Research Pathways
EuroGCT Key Resources
ATMP Engage
CARTALLEU
Actors and Network database
About Us
Contact
Breadcrumb
Home
Current and Potential Uses
Current and Potential Uses
Resources & Factsheets
EuroGCT Resource
What are 'unproven' therapies?
Related Topics
MSCs
Current and Potential Uses
Clinical Trials
Ethics and Society
Policy & Regulation
Unproven Treatments
Factsheets
EuroGCT Resource
Considering a treatment offer?
Related Topics
Cell Therapy
Clinical Trials
Current and Potential Uses
Gene Therapy
Unproven Treatments
EuroStemCell Resource
Video: Sporty Stem Cells - how stem cells can help cartilage injury
Related Topics
Bone and Muscle Conditions
Current and Potential Uses
English
EuroGCT Resource
Cystic fibrosis: how could gene and cell therapy help?
Related Topics
Cystic Fibrosis
Current and Potential Uses
Factsheets
EuroGCT Resource
Reproduction and fertility: how could gene and cell therapy help?
Related Topics
Reproduction and Fertility
iPS cells
EuroGCT Resource
Gene Horizons: Film and Toolkit
Related Topics
Sickle Cell Disease
Cancer
Immune Conditions
Cell and Gene Fundamentals
Genes and Inheritance
Current and Potential Uses
Gene Therapy
CAR-T Therapy
Gene Editing
EuroGCT Resource
What is gene and cell therapy?
Related Topics
Current and Potential Uses
Cell Therapy
Gene Therapy
Tissue Engineering
Gene Editing
English
EuroGCT Resource
Ethical questions in embryonic stem cell research
Related Topics
Embryonic Stem Cells
Current and Potential Uses
Ethics and Society
English
EuroGCT Resource
Age-related macular degeneration: how could gene and cell therapy help?
Related Topics
Eye Disease
Current and Potential Uses
Factsheets
English
EuroGCT Resource
Inherited retinal disorders (IRD): how could gene and cell therapy help?
Related Topics
Eye Disease
Current and Potential Uses
Factsheets
Pagination
Page
1
Page
2
Page
3
Page
4
Page
5
Page
6
Page
7
Next page
››
Last page
Last »